Work

Clinical Outcomes in Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated with Gilteritinib Who Received Prior Midostaurin or Sorafenib

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-136395

Authors: Alexander E. Perl, Jessica K. Altman, Naoko Hosono, Pau Montesinos, Nikolai A. Podoltsev, Giovanni Martinelli, Catherine C. Smith, Mark Levis, Christoph Röllig, Marco Groß-Langenhoff, Nahla Hasabou, Qiaoyang Lu, Ramon V. Tiu

Institutions: Abramson Cancer Center, University of Pennsylvania, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Fukui, Hospital Universitari i Politècnic La Fe, Yale University, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, University of California, San Francisco, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University Hospital Carl Gustav Carus, Astellas Pharma (Germany), Astellas Pharma (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095565609

FWCI: 0.953

Cites:

Cited by: 7

Related to: 10